Developing a Nomogram for Predicting Colorectal Cancer and Its Precancerous Lesions Based on Data from Three Non-Invasive Screening Tools, APCS, FIT, and sDNA
Yuan Ze,Hui-Ming Tu,Yuan-Yuan Zhao,Lin Zhang
DOI: https://doi.org/10.2147/jmdh.s465286
2024-06-15
Journal of Multidisciplinary Healthcare
Abstract:Yuan Ze, 1 Hui-Ming Tu, 2 Yuan-Yuan Zhao, 1 Lin Zhang 3, 4 1 Tumor Research and Therapy Center, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, People's Republic of China; 2 Department of Gastroenterology, Affiliated Hospital of Jiangnan University, Wuxi, 214122, People's Republic of China; 3 Institute of Artificial Intelligence, Hefei Comprehensive National Science Center, Hefei, 230026, People's Republic of China; 4 School of Population Medicine and Public Health, Peking Union Medical College/Chinese Academy of Medical Sciences, Beijing, 100053, People's Republic of China Correspondence: Hui-Ming Tu, Department of Gastroenterology, Affiliated Hospital of Jiangnan University, No. 1000, Hefeng Road, Binhu District, Wuxi, 214122, People's Republic of China, Tel +86-13861753621, Email Yuan-Yuan Zhao, Tumor Research and Therapy Center, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No. 324, Jingwu Weiqi Road, Huaiyin District, Jinan, 250021, People's Republic of China, Tel +86-13589097201, Email Purpose: This study aimed to develop and validate a nomogram for predicting positive colonoscopy results using the data from non-invasive screening strategies. Methods: The volunteers participated in primary colorectal cancer (CRC) screenings using Asia-Pacific colorectal screening (APCS) scoring, faecal immunochemical testing (FIT) and stool deoxyribonucleic acid (sDNA) testing and underwent a colonoscopy. The positive colonoscopy results included CRC, advanced adenoma (AA), high-grade intraepithelial neoplasia (HGIN), and low-grade intraepithelial neoplasia (LGIN). The enrolled participants were randomly selected for training and validation sets in a 7:3 ratio. A model for predicting positive colonoscopy results was virtualized by the nomogram using logistic regression analysis. Results: Among the 179 enrolled participants, 125 were assigned to training set, while 54 were assigned to validation set. After multivariable logistic regression was done, APCS score, FIT result, and sDNA result were all identified as the predictors for positive colonoscopy results. A model that incorporated the above independent predictors was developed and presented as a nomogram. The C-index of the nomogram in the validation set was 0.768 (95% CI, 0.644– 0.891). The calibration curve demonstrated a good agreement between prediction and observation. The decision curve analysis (DCA) curve showed that the model achieved a net benefit across all threshold probabilities. The AUC of the prediction model for predicting positive colonoscopy results was much higher than that of the FIT + sDNA test scheme. Conclusion: The nomogram for predicting positive colonoscopy results was successfully developed based on 3 non-invasive screening tools (APCS scoring, FIT and sDNA test). Keywords: nomogram, colorectal cancer, primary screening, faecal immunochemical testing, stool deoxyribonucleic acid Colorectal cancer (CRC) is the third most common cancer with about 1.8 million people affected globally in each year. 1 It remains the second leading cause of cancer worldwide, resulting in over 50,000 deaths annually. 1,2 The increasing incidence and mortality of CRC worldwide bring many challenges for public health. Due to the much better prognosis of patients with CRC diagnosed at early stages, early detection using the screening strategies is a promising method to reduce the burden of CRC. 3 Previous evidences have shown that screening significantly decrease CRC incidence and mortality. 4 Currently, the CRC screening strategies differ worldwide based on population risk and resources. 5 Colonoscopy is the golden diagnostic criteria for CRC with extremely high specificity. However, it also has many disadvantages, such as invasiveness, high cost and patient discomfort, which limit its clinical use. 6 The non-invasive screening strategies, including Asia-Pacific colorectal screening (APCS) scoring, fecal immunochemical testing (FIT), stool deoxyribonucleic acid (sDNA) test, CT colonography and blood-based tests, are more convenient and available for CRC screening. 5 APCS score is a well validated scoring system with an aim to assess the risk of CRC in Asian populations. 7 Previous studies have shown that APCS score achieves optimal primary screening efficiency with low cost-effectiveness. 8 However, the specificity of APCS score in CRC screening is very low; thus, other non-invasive strategies are suggested to combine with APCS score in order to improve the diagnostic accuracy. 6 FIT is highly sensitive in detectin -Abstract Truncated-
health care sciences & services